» Articles » PMID: 29693365

Identification of Key Candidate Genes and Pathways in Endometrial Cancer by Integrated Bioinformatical Analysis

Overview
Specialty Oncology
Date 2018 Apr 26
PMID 29693365
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Endometrial Cancer is the most common female genital tract malignancy, its pathogenesis is complex, not yet fully described. To identify key genes of Endometrial Cancer we downloaded the gene chip GSE17025 from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were identified through the GEO2R analysis tool. Functional and pathway enrichment analysis were performed for DEGs using DAVID database. The network of protein–protein-interaction (PPI) was established by STRING website and visualized by Cytoscape. Then, functional and pathway enrichment analysis of DEGS were performed by DAVID database. A total of 1000 significant differences genes were obtained, contain 362 up-regulated genes and 638 down-regulated genes. PCDH10, SLC6A2, OGN, SFRP4, TRH, ANGPTL, FOSB are down-regulated genes. The gene of IGH, CCL20, ELF5, LTF, ASPM expression level in tumor patients are up-regulated. Biological function of enrichment include metabolism of xenobiotics by cytochrome P450, MAPK signaling pathway, Serotonergic synapse, Protein digestion and absorption, IL-17 signaling pathway, Chemokine signaling pathway, HIF-1 signaling pathway, p53 signaling pathway. All in all, the current study to determine endometrial differentially expressed genes and biological function, comprehensive analysis of intrauterine membrane carcinoma pathogenesis mechanism, and might be used as molecular targets and diagnostic biomarkers for the treatment of endometrial cancer.

Citing Articles

Shared genetic aetiology of Alzheimer's disease and age-related macular degeneration by APOC1 and APOE genes.

Zhang X, Zhu Z, Huang Y, Shang X, OBrien T, Kwan P BMJ Neurol Open. 2024; 6(1):e000570.

PMID: 38646507 PMC: 11029327. DOI: 10.1136/bmjno-2023-000570.


Bioinformatics and pathway enrichment analysis identified hub genes and potential biomarker for gastric cancer prognosis.

Darang E, Pezeshkian Z, Mirhoseini S, Ghovvati S Front Oncol. 2023; 13:1187521.

PMID: 37361568 PMC: 10288990. DOI: 10.3389/fonc.2023.1187521.


The role of Pcdh10 in neurological disease and cancer.

Zhen Y, Pavez M, Li X J Cancer Res Clin Oncol. 2023; 149(10):8153-8164.

PMID: 37058252 PMC: 10374755. DOI: 10.1007/s00432-023-04743-w.


The roles and clinical applications of interleukins in endometrial carcinoma.

Zang Y, Li H, Liu S, Zhao R, Zhang K, Zang Y Front Oncol. 2022; 12:1001693.

PMID: 36531027 PMC: 9748080. DOI: 10.3389/fonc.2022.1001693.


Diagnosis and Prediction of Endometrial Carcinoma Using Machine Learning and Artificial Neural Networks Based on Public Databases.

Zhao D, Zhang Z, Wang Z, Du Z, Wu M, Zhang T Genes (Basel). 2022; 13(6).

PMID: 35741697 PMC: 9222484. DOI: 10.3390/genes13060935.


References
1.
Bersinger N, Schneider B, Vorburger S, Johann S, Candinas D, Mueller M . Prognostic value of tumour endothelial markers in patients with endometrial cancer. Oncol Lett. 2012; 1(1):203-207. PMC: 3436417. DOI: 10.3892/ol_00000037. View

2.
Zhao Y, Yang Y, Trovik J, Sun K, Zhou L, Jiang P . A novel wnt regulatory axis in endometrioid endometrial cancer. Cancer Res. 2014; 74(18):5103-17. DOI: 10.1158/0008-5472.CAN-14-0427. View

3.
Husseinzadeh N, Davenport S . Role of toll-like receptors in cervical, endometrial and ovarian cancers: a review. Gynecol Oncol. 2014; 135(2):359-63. DOI: 10.1016/j.ygyno.2014.08.013. View

4.
Barrett T, Wilhite S, Ledoux P, Evangelista C, Kim I, Tomashevsky M . NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2012; 41(Database issue):D991-5. PMC: 3531084. DOI: 10.1093/nar/gks1193. View

5.
Piulats J, Guerra E, Gil-Martin M, Roman-Canal B, Gatius S, Sanz-Pamplona R . Molecular approaches for classifying endometrial carcinoma. Gynecol Oncol. 2017; 145(1):200-207. DOI: 10.1016/j.ygyno.2016.12.015. View